Satellite Biosciences, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Satellite Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2022).
SEC Form D · Mar 2022
The industry group it chose in its notices: Biotechnology.
SEC Form D · Mar 2022
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Satellite Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David Lennon | Executive officer | Mar 2022 |
| Diane Marcou | Executive officer | Mar 2022 |
| Laura Lande-Diner | Executive officer | Mar 2022 |
| Thomas Lowery | Executive officer | Nov 2020 |
| Christopher Chen | Director | Mar 2022 |
| David Lennon | Director | Mar 2022 |
| Eileen McGuire | Director | Mar 2022 |
| Ling Wong | Director | Mar 2022 |
| William Young | Director | Mar 2022 |
| Yair Schindel | Yair Schindel was elected as a Director upon the Date of First Sale. | Mar 2022 |
| Ellie McGuire | Ellie McGuire was elected as a Director upon the Date of First Sale. | Nov 2020 |
| Sujata Bhatia | Sujata Bhatia served as a Director on the date the Board of Directors approved the offering. She resigned as a Director | Nov 2020 |
| Christopher Chen | Promoter | Mar 2022 |
| Sangeeta Bhatia | Promoter | Mar 2022 |